• Users Online: 587
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2016  |  Volume : 2  |  Issue : 1  |  Page : 48-53

Methylene blue treatment in experimental ischemic stroke: A mini-review


1 Research Imaging Institute, Radiology, University of Texas Health Science Center, San Antonio, Texas, USA
2 Department of Ophthalmology, Radiology and Physiology, University of Texas Health Science Center, San Antonio, Texas, USA

Correspondence Address:
Dr. Zhao Jiang
Research Imaging Institute, Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2394-8108.178548

Rights and Permissions

Stroke is among the leading causes of death and long-term disability. Methylene blue (MB), a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neurodegenerative diseases and brain injuries. The goal of this paper is to review studies on MB in experimental stroke models.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4438    
    Printed170    
    Emailed0    
    PDF Downloaded363    
    Comments [Add]    
    Cited by others 14    

Recommend this journal